Dr. Puri’s first venture, InnoPharma, was founded in 2005 with a focus on developing complex generic pharmaceuticals of sterile injectable dose forms. This was sold to Pfizer in 2014. Puri went on to found Nevakar, which is a specialty pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space…